#OpioidReceptors #Analgesia #PainManagement #PalliativeCare #AddictionMedicine #BCPMPExam #PharmlessHealth To view or add a comment, sign in Drug Update: Orforglipron (Foundayo) A major advancement in obesity management has arrived with the approval of orforglipron, a once-daily oral GLP-1 receptor agonist
doi: 10.1016/S0165-6147(03)00160-3 139 TimmersLHenriquesJPSde KleijnDPVDevriesJHKempermanHSteendijkPet al
Patients taking antispasmodics (dicyclomine, hyoscyamine), fiber supplements, or gut-directed therapies should maintain these unless side effects become problematic
The renowned surgeon will be visited by our group.
However, consult your healthcare provider if you: Are pregnant or breastfeeding Have liver or kidney impairment Take prescription medications that interact with antioxidants or sulfur compounds (e.g., penicillin) This product supports cellular function and antioxidant balance, but does not replace medical treatment or prescribed therapies